ALAB three-lens brief
Evidence-based stock research on ALAB. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 6.81% in the last session — a material single-day move. · Trading >3% below the 50-day MA — short-term weakness.
- Price up 6.81% in the last session — a material single-day move.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 34.8pp over 30 days.
- P/E of 91 — priced for high growth; little margin of safety.
- Analyst mean target $344.15 — 49% above current (22 analysts).
ALAB closed at $230.91 (+6.81%) as of 2026-11-12. Market cap: $40.36B. P/E (trailing) 91.3. Price is below the 50-day MA and below the 200-day MA. Positives: price up 6.81% in the last session — a material single-day move.; analyst mean target $344.15 — 49% above current (22 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 34.8pp over 30 days.. Last quarter: Revenue $584.90M, net income $182.94M, free cash flow $131.36M.
Why three lenses on ALAB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALAB across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ALAB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALAB brief"></iframe>